Legal & General Group
BEAM icon

Legal & General Group’s Beam Therapeutics BEAM Stock Holding History

Legal & General Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Sell
81,912
-10,166
-11% -$282K ﹤0.01% 1919
2025
Q4 		$2.55M Sell
92,078
-7,490
-8% -$191K ﹤0.01% 1874
2025
Q3 		$2.42M Sell
99,568
-3,078
-3% -$61.2K ﹤0.01% 1901
2025
Q2 		$1.75M Buy
102,646
+8,023
+8% +$140K ﹤0.01% 2016
2025
Q1 		$1.85M Buy
94,623
+21,281
+29% +$557K ﹤0.01% 1955
2024
Q4 		$1.82M Buy
73,342
+1,586
+2% +$40.5K ﹤0.01% 2009
2024
Q3 		$1.76M Buy
71,756
+1,117
+2% +$28.9K ﹤0.01% 2035
2024
Q2 		$1.66M Sell
70,639
-2,919
-4% -$71.7K ﹤0.01% 2025
2024
Q1 		$2.43M Buy
73,558
+3,010
+4% +$93.8K ﹤0.01% 1849
2023
Q4 		$1.92M Buy
70,548
+822
+1% +$20.4K ﹤0.01% 1977
2023
Q3 		$1.68M Buy
69,726
+14,463
+26% +$388K ﹤0.01% 1976
2023
Q2 		$1.76M Sell
55,263
-891
-2% -$28.9K ﹤0.01% 1982
2023
Q1 		$1.72M Buy
56,154
+2,929
+6% +$116K ﹤0.01% 1945
2022
Q4 		$2.08M Sell
53,225
-659
-1% -$29.5K ﹤0.01% 1868
2022
Q3 		$2.57M Sell
53,884
-2,640
-5% -$151K ﹤0.01% 1730
2022
Q2 		$2.19M Buy
56,524
+13,863
+32% +$551K ﹤0.01% 1847
2022
Q1 		$2.44M Buy
42,661
+4,275
+11% +$280K ﹤0.01% 1898
2021
Q4 		$3.06M Buy
38,386
+1,179
+3% +$101K ﹤0.01% 1835
2021
Q3 		$3.24M Buy
37,207
+7,904
+27% +$794K ﹤0.01% 1766
2021
Q2 		$3.77M Buy
29,303
+4,108
+16% +$327K ﹤0.01% 1685
2021
Q1 		$2.02M Buy
25,195
+16,994
+207% +$1.62M ﹤0.01% 1979
2020
Q4 		$669K Buy
8,201
+3,210
+64% +$158K ﹤0.01% 2198
2020
Q3 		$123K Buy
4,991
+2,260
+83% +$56.1K ﹤0.01% 2436
2020
Q2 		$77K Buy
2,731
+824
+43% +$17.8K ﹤0.01% 2599
2020
Q1 		$34K Buy
+1,907
New +$41.4K ﹤0.01% 2718

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Legal & General Group's BEAM Position: Q1 2026 in Review

Legal & General Group reduced its Beam Therapeutics (BEAM) stake by 11% in Q1 2026, selling an estimated $282K and leaving 81,912 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Legal & General Group first reported a position in BEAM in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.77M in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Legal & General Group held 81,912 shares of Beam Therapeutics worth $1.95M as of Q1 2026.
  • Legal & General Group sold 10,166 Beam Therapeutics shares in Q1 2026, an estimated $282K.
  • Beam Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1919 holding.
  • Legal & General Group first reported a position in Beam Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Legal & General Group's Beam Therapeutics position peaked at $3.77M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.